Orthopaedic surgeons often require highly specialized medical devices, implants, and equipment, which are usually offered by several vendors/companies. This study assesses long-term market trends for orthopaedic medical device companies and examines various implications for healthcare cost. Using S&P Capital IQ, a Wall Street database, financial data were gathered on orthopaedic device companies, ranked by worldwide sales, from 1999 to 2015. Annual sales were aggregated to calculate market share and compounded annual growth rates (CAGRs). Overall, the global orthopaedic device market grew at 12.0% CAGR from 1999 to 2008, before slowing to 2.8% from 2009 to 2015. Between 1999 and 2015, the top 5 companies increased total market share from 52.8 to 62.2%. The orthopaedic device market is not only consolidating under a few dominant players, but also growing at a decreasing rate, both of which signal a maturing industry. These trends are likely to shape patient care and healthcare costs in orthopaedic surgery in years to come.
Orthopaedics Medical devices Market share Industry growth
This is a preview of subscription content, log in to check access.
Compliance with ethical standards
Conflict of interest
Dr. Piuzzi has nothing to disclose. Mr. Ng reports personal fees from Thessalus Capital, outside the submitted work; Mr. Song has nothing to disclose. Mr. Bigach has nothing to disclose. Dr. Khlopas has nothing to disclose. Dr. Salas-Vega has nothing to disclose. Dr. Mont reports other from Abbot, other from Cymedica, other from DJ Orthopaedics, other from Johnson & Johnson, other from Mallinckrodt Pharmaceuticals, other from Microport, other from Ongoing Care Solutions, other from OrthoSensor, other from Pacira, other from Peerwell, other from Performance Dynamics, other from Sage, other from Stryker, other from TissueGene, outside the submitted work.